NZ Lung Cancer Research Review Issue 8

In this issue:

Cigarettes: graphic health warnings and plain packaging
Timing of palliative care referral
NZ data on endobronchial ultrasound
Cost-effectiveness of lung cancer screening in NZ
Barriers to accessing lung cancer care
Transformed EGFR-mutant lung cancers
Durvalumab after chemoradiotherapy
Atezolizumab plus chemotherapy
Pembrolizumab plus chemotherapy
Checkpoint inhibitor pneumonitis

Please login below to download this issue (PDF)

Subscribe